BIOCHEMICAL SOCIETY TRANSACTIONS several laboratories to identify and isolate the proton pumps of lysosomes, endosomes and coated vesicles; such studies will undoubtedly lead to a greater understanding of both the molecular mechanism of these proton-translocating enzymes and the processes involved in regulating membrane traffic between the cell surface and intracellular organelles.
It is well accepted that the lysosome is the intracellular site where most macromolecules are degraded. Although the processes by which macromolecules enter the lysosomal apparatus have been extensively studied, much less is known about the fate of the lysosomal digestion products of these macromolecules. Most early studies seemed to assume that if the digestive products were small enough they might simply diffuse into the cytoplasm or extracellular fluid where they could be metabolized further, and studies were focused on the permeability of the lysosomal membrane to various compounds. The classic approach was to relate the permeability of different compounds to changes in lysosoma1 latency (e.g. Lloyd, 1969 Lloyd, , 1971 . Reijngoud & Tager (1977) have pointed out, however, that such studies estimate the passage of the compound from cytosol to lysosome (i.e. neutral pH to acid pH), whereas in the physiological situation the compound moves in the opposite direction. Thus, the results of such experiments in vitro may not reflect the situation in vivo.
The studies of Ehrenreich & Cohn (1969) represented a different approach to the question of lysosomal permeability. They incubated mouse peritoneal macrophages with a series of small peptides, many of which contained D-amino acids and were thus 'non-metabolizable'. The peptides entered the lysosome by pinocytosis. Those that led to lysosomal swelling (vacuolization) were assumed to be unable to penetrate the lysosomal membrane. Those which did not result in vacuolization were either able to penetrate the lysosomal membrane or were digested to smaller products which could penetrate the membrane. These results suggested that molecular size was a major determinant of whether or not a peptide was permeable to the lysosomal membrane. The impermeable compounds had molecular weights of greater than 220.
An early attempt to define a specific lysosomal transport system was reported by Docherty et al. (1979) . Using the osmotic-protection method, these workers showed that sugars enter rat liver lysosomes by a process that is sugar specific, stereospecific, inhibitable by phlorrhizin and cyto- chalasin B, demonstrates competition between sugars and has a rate response to temperature change, all characteristics of transport processes. More recently, this group (Maguire et al., 1983) have performed 'direct' transport studies in rat liver 'tritosomes' to demonstrate the presence of a facilitated-diffusion transport system for sugars in these purified lysosomes.
While studying the incorporation of extracellular amino acids into cell protein, many investigations obtained data which could best be explained by the existence of a separate (Table 1) . These data suggested that there might be specific lysosomal transport processes for amino acids.
The strongest evidence for a specific lysosomal transport system comes from study of mutant cells which have a defect in lysosomal cystine efflux (Schneider & Schulman, 1982; Gahl er al., 1982u,b, 1983 Jonas et al., 1982b Jonas et al., , 1983 . Cystinosis is a recessively inherited metabolic disorder characterized biochemically by a high intracellular content of free (non-protein) cystine that is compartmentalized within lysosomes (Schneider & Schulman, 1982) . Children with this disorder develop renal, retinal and thyroid damage, and without medical intervention, death ultimately occurs by about 10 years of age from renal failure. Fifty years of investigation by various laboratories have recently culminated in an understanding of this unusual disorder. The failure of numerous laboratories to find a defect in cystine metabolism in cystinotic tissue suggested the possibility of a transport defect (Segal, 1965 ). Attempts to demonstrate a defect in cystine transport at the plasma membrane were complicated by the rapid metabolism of intracellular cystine and cysteine and the large, pre-existing pool of lysosomal cystine in cystinotic cells (Schneider er al., 1968; States et al., 1974 States et al., , 1981 .
Since cystine is localized in lysosomes of cystinotic cells, lysosomal cystine transport seemed a likely candidate for the inherited defect in this disorder. Until recently, however, studies of lysosomal transport were not possible because of our inability to load lysosomes with cystine. Two methods have recently been described to accomplish this task. One method requires incubation of cells in cysteine-608th MEETING, KEELE glutathione mixed disulphide (Jonas et al., 1982a) , and the other in cystine dimethyl ester (Goldman & Kaplan, 1973; Reeves, 1979; Steinherz et al., 1982a,b; Jonas et al., 19826, 1983) . Our laboratory initially investigated the mixed disulphide of cysteine and glutathione as a non-toxic, soluble source of cystine for cystinotic cells (Jonas et al., 1982~) . With this compound we were able to increase the free cystine content of normal control fibroblasts about 6-fold. All of the detectable intracellular cystine was intralysosomal. These normal cells rapidly lost their elevated cystine content, returning to control levels of cystine after 90min of incubation in a cystine-free medium. When cystinotic fibroblasts were depleted of cystine (by incubation in cysteamine; Thoene et al., 1976) and then reloaded with cystine using the mixed disulphide, as with the normal control fibroblasts described above, they did not lose a significant amount of cystine after a 90min incubation in cystine-free medium.
Lysosomes were isolated from cystinotic and normal control fibroblasts that had been treated with cysteineglutathione mixed disulphide to increase their cystine content. In contrast to the results in intact cells, cystine loss could not be demonstrated from the lysosomes of either cell type when incubated at 37°C for 30min (Jonas et al., 1982a) . The reason for this discrepancy will be discussed below. Steinherz et al. (19823) did similar experiments in peripheral leucocytes from cystinotic and normal control individuals. 'They loaded these celIs with cystine by incubation in cystine dimethyl ester. In intact cells their results were very similar to those of Jonas et al. (1982a) described above. However, in isolated peripheral leucocyte lysosomes this group was able to demonstrate that the cystine transport system was defective (Gahl et al., 1982u,b) . The rate of cystine efflux from normal lysosomes was enhanced by the addition of ATP, but ATP was not necessary to demonstrate the marked difference in cystine efflux between normal and cystinotic lysosomes.
Meanwhile our laboratory had found that the loss of cystine from normal intact (cystine-loaded) cells was markedly inhibited when the cells were depleted of 80% of their ATP by placement in medium containing 0.2 m~-2,4-dinitrophenol (Jonas et al., 19823) . Utilizing Epstein-Barrvirus-transformed lymphoblasts from normal individuals and loading these cells with cystine by using the cystine dimethyl ester, we could demonstrate that lysosomal cystine efflux was greatly enhanced by exogenous ATP (Jonas et al., 19826) . Cystine efflux was much lower, and was unresponsive to ATP in cystinotic lysosomes (Fig. 1) .
Further study of purified lysosomes from Epstein-Barrvirus-transformed human lymphoblasts showed that they contained a proton-translocating ATPase (Jonas et al., 1983) . Activity of this ATPase caused acidification of highly purified, fluorescein isothiocyanate dextran-loaded lysosomes and correlated with the ATPdependent efflux of lysosomal cystine (Table 2 ). The fact that the protonophore, carbonyl cyanide m-chlorophenylhydramne, which inhibits lysosomal acidification, but not ATP hydrolysis, also inhibits cystine efflux suggests that a pH gradient across the lysosomal membrane is necessary for cystine efflux. Although ATP-dependent lysosomal cystine efflux is not demonstrable in cultured lymphoblasts from individuals with nephropathic cystinosis, ATPase activity and acidification in lysosomes from these cells is comparable with that in non-cystinotic lysosomes (Jonas et al., 1983) . Gahl et al. (1983) have now shown that the defective cystine efflux in cystinotic lysosomes can also be demonstrated by the lack of counter-transport in these preparations. This is strong evidence that the normal process of lysosomal cystine efflux is carrier-mediated.
Thus, the availability of a mutant has provided the most incontrovertible evidence to date for a specific transport process for the efflux of a lysosomal digestion product. One can only speculate as to how many other 'digestive products' have specific lysosomal transport systems, and to whether or not other mutants defective in such a system exist.
